These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19931978)

  • 1. Re: Richard J. Sylvester, Willem Oosterlinck. An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed? Eur Urol 2009;56;43-5.
    Gudjónsson S; Månsson W; Holmäng S; Liedberg F
    Eur Urol; 2010 Mar; 57(3):e28-9; author reply e30. PubMed ID: 19931978
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Willem Oosterlinck,Richard Sylvester, Marco Babjuk, et al. Should all patients receive an immediate chemotherapeutic drug instillation after resection of papillary bladder tumors? Eur Urol 2011;59:374-6.
    Gudjónsson S
    Eur Urol; 2011 Jul; 60(1):e2-3; author reply e4. PubMed ID: 21531071
    [No Abstract]   [Full Text] [Related]  

  • 3. An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed?
    Sylvester RJ; Oosterlinck W
    Eur Urol; 2009 Jul; 56(1):43-5. PubMed ID: 19375216
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply from authors re: Marko Babjuk. Second resection for non-muscle-invasive bladder carcinoma: current role and future perspectives. Eur Urol 2010;58:191-2 and Giacomo Novara, Vincenzo Ficarra. Does routine second transurethral resection affect the long-term outcome of patients with T1 bladder cancer? Why a flawed randomized controlled trial cannot address the issue. Eur Urol 2010;58:193-4.
    Divrik RT; Sahin AF; Ergör G
    Eur Urol; 2010 Aug; 58(2):195-6. PubMed ID: 20471156
    [No Abstract]   [Full Text] [Related]  

  • 5. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
    Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
    Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.
    Hendricksen K; Gleason D; Young JM; Saltzstein D; Gershman A; Lerner S; Witjes JA
    J Urol; 2008 Jul; 180(1):116-20. PubMed ID: 18485407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol 2009;56:247-56.
    Lamm D; Böhle A; Palou J; Persad R; Brausi M; Colombel M; Akaza H; Buckley R
    Eur Urol; 2010 Feb; 57(2):e7-9; author reply e10-1. PubMed ID: 19914768
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences: I. Berrum-svennung, T. Granfors, S. Jahnson, H. Boman and S. Holmang. J Urol 2008; 179: 101-106.
    Oosterlinck W; Sylvester R
    J Urol; 2008 Nov; 180(5):2255-6; author reply 2256. PubMed ID: 18804803
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Herr HW
    Eur Urol; 2009 Apr; 55(4):920-1. PubMed ID: 18722043
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Witjes JA
    Eur Urol; 2009 Apr; 55(4):919. PubMed ID: 18722044
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.050.
    Williams SB; Lamm DL; Kamat AM
    Eur Urol; 2015 Dec; 68(6):e127. PubMed ID: 26318707
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed healing at transurethral resection of bladder tumour sites after immediate postoperative mitomycin C instillation.
    Aagaard MF; Mogensen K; Hermann GG
    Scand J Urol; 2014 Apr; 48(2):222-4. PubMed ID: 23870006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perivesical inflammation and necrosis due to mitomycin C instillation after transurethral resection of bladder tumor: we must be vigilant!
    Fazlioglu A; Tandogdu Z; Kurtulus FO; Parlakkilic O; Cek M
    Urol Int; 2009; 83(3):362-3. PubMed ID: 19829042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral resection in regionally advanced bladder cancer.
    Herr HW
    Urol Clin North Am; 1992 Nov; 19(4):695-700. PubMed ID: 1441026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of post-operative intravesical mitomycin C instillation following transurethral bladder tumor resection.
    Shapiro O; Jones K; Wang C; Landas S; Haas GP
    Can J Urol; 2006 Dec; 13(6):3317-20. PubMed ID: 17187694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.050.
    Malmström PU; Trock BJ
    Eur Urol; 2016 Jan; 69(1):e10-1. PubMed ID: 26215603
    [No Abstract]   [Full Text] [Related]  

  • 17. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Solsona E; Climent MA; Iborra I; Collado A; Rubio J; Ricós JV; Casanova J; Calatrava A; Monrós JL
    Eur Urol; 2009 Apr; 55(4):911-9. PubMed ID: 18722046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of simultaneous transurethral resection of bladder tumor and prostate in patients with nonmuscle invasive bladder tumor and bladder outlet obstruction.
    Ham WS; Kim WT; Jeon HJ; Lee DH; Choi YD
    J Urol; 2009 Apr; 181(4):1594-9; discussion 1599. PubMed ID: 19230913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebuttal from author re: Axel Heidenreich. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ preserving therapy in carefully selected patients. Eur Urol 2008;54:21-23.
    Herr HW
    Eur Urol; 2008 Jul; 54(1):23-4. PubMed ID: 18262335
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? H. W. Herr, S. M. Donat and G. Dalbagni J Urol 2007; 177: 75-79.
    Nieder AM; Soloway MS; Jewett MA
    J Urol; 2007 Jul; 178(1):352. PubMed ID: 17507038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.